214 related articles for article (PubMed ID: 22275836)
1. RGD-modified poly(D,L-lactic acid) nanoparticles enhance tumor targeting of oridonin.
Xu J; Zhao JH; Liu Y; Feng NP; Zhang YT
Int J Nanomedicine; 2012; 7():211-9. PubMed ID: 22275836
[TBL] [Abstract][Full Text] [Related]
2. Studies on the oridonin-loaded poly(D,L-lactic acid) nanoparticles in vitro and in vivo.
Xing J; Zhang D; Tan T
Int J Biol Macromol; 2007 Jan; 40(2):153-8. PubMed ID: 16901536
[TBL] [Abstract][Full Text] [Related]
3. RGD-conjugated PLA-PLL nanoparticles targeting to Bacp-37 breast cancer xenografts in vivo.
Liu P; Qi X; Sun Y; Wang H; Li Y; Duan Y
J Nanosci Nanotechnol; 2011 Dec; 11(12):10760-4. PubMed ID: 22408990
[TBL] [Abstract][Full Text] [Related]
4. Antitumor activity of docetaxel-loaded polymeric nanoparticles fabricated by Shirasu porous glass membrane-emulsification technique.
Yu Y; Tan S; Zhao S; Zhuang X; Song Q; Wang Y; Zhou Q; Zhang Z
Int J Nanomedicine; 2013; 8():2641-52. PubMed ID: 23935362
[TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo evaluation of oridonin-loaded long circulating nanostructured lipid carriers.
Jia L; Shen J; Zhang D; Duan C; Liu G; Zheng D; Tian X; Liu Y; Zhang Q
Int J Biol Macromol; 2012 Apr; 50(3):523-9. PubMed ID: 22301003
[TBL] [Abstract][Full Text] [Related]
6. Oridonin-loaded poly(epsilon-caprolactone)-poly(ethylene oxide)-poly(epsilon-caprolactone) copolymer nanoparticles: preparation, characterization, and antitumor activity on mice with transplanted hepatoma.
Feng N; Wu P; Li Q; Mei Y; Shi S; Yu J; Xu J; Liu Y; Wang Y
J Drug Target; 2008 Jul; 16(6):479-85. PubMed ID: 18604660
[TBL] [Abstract][Full Text] [Related]
7. Galactosylated chitosan nanoparticles for hepatocyte-targeted delivery of oridonin.
Zheng D; Duan C; Zhang D; Jia L; Liu G; Liu Y; Wang F; Li C; Guo H; Zhang Q
Int J Pharm; 2012 Oct; 436(1-2):379-86. PubMed ID: 22732673
[TBL] [Abstract][Full Text] [Related]
8. GE11 peptide conjugated selenium nanoparticles for EGFR targeted oridonin delivery to achieve enhanced anticancer efficacy by inhibiting EGFR-mediated PI3K/AKT and Ras/Raf/MEK/ERK pathways.
Pi J; Jiang J; Cai H; Yang F; Jin H; Yang P; Cai J; Chen ZW
Drug Deliv; 2017 Nov; 24(1):1549-1564. PubMed ID: 29019267
[TBL] [Abstract][Full Text] [Related]
9. The design and synthesis of redox-responsive oridonin polymeric prodrug micelle formulation for effective gastric cancer therapy.
Xu L; Zhu L; Zheng K; Liu J; Tian P; Hu D; Wang Q; Zuo Q; Ouyang X; Dai Y; Fu Y; Dai X; Huang F; Cheng J
J Mater Chem B; 2021 Apr; 9(13):3068-3078. PubMed ID: 33885668
[TBL] [Abstract][Full Text] [Related]
10. Discovery and in vivo evaluation of novel RGD-modified lipid-polymer hybrid nanoparticles for targeted drug delivery.
Zhao Y; Lin D; Wu F; Guo L; He G; Ouyang L; Song X; Huang W; Li X
Int J Mol Sci; 2014 Sep; 15(10):17565-76. PubMed ID: 25268623
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics and biodistribution of surface modification polymeric nanoparticles.
Liu M; Li H; Luo G; Liu Q; Wang Y
Arch Pharm Res; 2008 Apr; 31(4):547-54. PubMed ID: 18449515
[TBL] [Abstract][Full Text] [Related]
12. Angelica Sinensis Polysaccharide-Based Nanoparticles for Liver-Targeted Delivery of Oridonin.
Sun H; Nai J; Deng B; Zheng Z; Chen X; Zhang C; Sheng H; Zhu L
Molecules; 2024 Feb; 29(3):. PubMed ID: 38338476
[TBL] [Abstract][Full Text] [Related]
13. Biodegradable self-assembled MPEG-PCL micelles for hydrophobic oridonin delivery in vitro.
Xue B; Wang Y; Tang X; Xie P; Wang Y; Luo F; Wu C; Qian Z
J Biomed Nanotechnol; 2012 Feb; 8(1):80-9. PubMed ID: 22515096
[TBL] [Abstract][Full Text] [Related]
14. Improved antifungal activity of itraconazole-loaded PEG/PLA nanoparticles.
Essa S; Louhichi F; Raymond M; Hildgen P
J Microencapsul; 2013; 30(3):205-17. PubMed ID: 22894166
[TBL] [Abstract][Full Text] [Related]
15. Oridonin nanosuspension enhances anti-tumor efficacy in SMMC-7721 cells and H22 tumor bearing mice.
Lou H; Gao L; Wei X; Zhang Z; Zheng D; Zhang D; Zhang X; Li Y; Zhang Q
Colloids Surf B Biointerfaces; 2011 Oct; 87(2):319-25. PubMed ID: 21676599
[TBL] [Abstract][Full Text] [Related]
16. [Preparation and in vitro evaluation of brucine-loaded polylacticacid nanoparticles].
Zhao J; Liu Z; Xu J; Yu Y; Feng N
Zhongguo Zhong Yao Za Zhi; 2009 Sep; 34(18):2322-4. PubMed ID: 20030079
[TBL] [Abstract][Full Text] [Related]
17. Brain pharmacokinetics of neurotoxin-loaded PLA nanoparticles modified with chitosan after intranasal administration in awake rats.
Zhang X; Liu L; Chai G; Zhang X; Li F
Drug Dev Ind Pharm; 2013 Nov; 39(11):1618-24. PubMed ID: 24087853
[TBL] [Abstract][Full Text] [Related]
18. Efficient delivery of antitumor drug to the nuclei of tumor cells by amphiphilic biodegradable poly(L-aspartic acid-co-lactic acid)/DPPE co-polymer nanoparticles.
Han S; Liu Y; Nie X; Xu Q; Jiao F; Li W; Zhao Y; Wu Y; Chen C
Small; 2012 May; 8(10):1596-606. PubMed ID: 22411637
[TBL] [Abstract][Full Text] [Related]
19. Novel multi-biotin grafted poly(lactic acid) and its self-assembling nanoparticles capable of binding to streptavidin.
Yan H; Jiang W; Zhang Y; Liu Y; Wang B; Yang L; Deng L; Singh GK; Pan J
Int J Nanomedicine; 2012; 7():457-65. PubMed ID: 22334778
[TBL] [Abstract][Full Text] [Related]
20. Multifunctional pH-sensitive polymeric nanoparticles for theranostics evaluated experimentally in cancer.
Liu Y; Feng L; Liu T; Zhang L; Yao Y; Yu D; Wang L; Zhang N
Nanoscale; 2014 Mar; 6(6):3231-42. PubMed ID: 24500240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
